From Financial Modeling Prep: 2025-05-07 09:05:00

Charles River Laboratories International, Inc. (NYSE:CRL) shares jumped 19% after governance changes and strong Q1 earnings. Four new directors will join the board as part of a strategic review to optimize operations. Q1 earnings beat expectations with EPS of $2.34 and revenue of $984.2 million. CEO Foster is optimistic about future growth.



Read more at Financial Modeling Prep:: Charles River Laboratories (NYSE:CRL) Sees 19% Jum…